Respiratory News and Research

RSS

Queen's doctor plays key role in major breakthrough to change lives of cystic fibrosis sufferers

A Queen's University doctor has played a key role in a major breakthrough to change the lives of cystic fibrosis sufferers.

26 Jun 2014

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Henry Ford Health System has launched a clinical trial to investigate a new drug for the treatment of tinnitus, a chronic ringing of the head or ears that affects more than 600 million people worldwide.

25 Jun 2014

St. Mary's Medical Center honored with Healthgrades 2014 Women's Health Excellence Award

Dignity Health St. Mary's Medical Center has received the 2014 Women's Health Excellence Award from Healthgrades, the leading online resource for comprehensive information about physicians and hospitals.

25 Jun 2014

Trevena's Phase 1b data for TRV130 published in the journal Pain

Trevena, Inc., a clinical stage biopharmaceutical company and the leader in the discovery of G protein coupled receptor (GPCR) biased ligands, today announced the publication of its Phase 1b data for TRV130 in the journal Pain.

24 Jun 2014

Nearly 4% of U.S. babies are born before full-term without medical indication, study finds

A large new study, covering millions of U.S. births over 15 years, finds that substantial numbers of babies, nearly one in 25, are born earlier than medically justified, through elective cesarean sections and elective induced labor. The study reinforces long-standing recommendations by professional medical and public health organizations against early-term deliveries without appropriate medical reasons.

24 Jun 2014

Forest Laboratories reports positive results from three Phase III trials of vilazodone for GAD treatment

Forest Laboratories, Inc. today announced positive topline results from three Phase III trials evaluating the efficacy, safety and tolerability of vilazodone in adult patients with generalized anxiety disorder (GAD).

24 Jun 2014

Scientists turn to old class of antibiotics to fight superbugs resistant to modern medicine

Scientists at the University at Buffalo are turning to an old class of antibiotics to fight new superbugs resistant to modern medicine.

24 Jun 2014

Private insurers clamp down on drug prices

More health plans are refusing to cover certain brand-name drugs unless drugmakers offer discounts for them, reports The New York Times.

23 Jun 2014

Aradigm begins Pulmaquin Phase III study for treatment of non-CF BE

Aradigm Corporation ("Aradigm" or the "Company") today announced the dosing of the first patient in the ORBIT-4 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) Phase III pivotal clinical trial of Aradigm's proprietary formulation of inhaled ciprofloxacin (Pulmaquin®) for the treatment of non-cystic fibrosis bronchiectasis (non-CF BE).

23 Jun 2014

Trevena reports positive results from TRV734 Phase 1 trial for treating acute/chronic pain

Trevena, Inc. (NASDAQ:TRVN) today announced positive results from its Phase 1 trial of TRV734, which Trevena is developing with the goal of providing improved analgesia while avoiding gastrointestinal and respiratory side effects typically associated with opioids.

23 Jun 2014

First Edition: June 23, 2014

Today's early morning highlights from the major news organizations, including news stories about healthcare.gov management changes.

23 Jun 2014

National, state air pollution controls decrease death rates in North Carolina

National and state air pollution controls that went into effect in the early 1990s coincide with decreasing death rates from emphysema, asthma and pneumonia among people in North Carolina, according to a study led by Duke University researchers.

23 Jun 2014

New mobile app can measure respiratory rate in children 6 times faster than manual method

A new mobile app developed by researchers at the Child & Family Research Institute (CFRI) at BC Children's Hospital and the University of British Columbia can measure respiratory rate in children roughly six times faster than the standard manual method.

20 Jun 2014

Research provides unique insight into lncRNAs that regulate lung development

It's a long way from DNA to RNA to protein, and only about two percent of a person's genome is eventually converted into proteins.

19 Jun 2014

Researchers identify MERS-related abnormality distribution on CT imaging of patients

Researchers in Saudi Arabia have identified key defining characteristics of Middle East Respiratory Syndrome (MERS) in CT imaging of patients confirmed as having the disease.

19 Jun 2014

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

Janssen Pharmaceuticals, Inc.announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A.

18 Jun 2014

Walgreens, Heritage Provider Network sign clinical care collaboration agreement

Walgreens, the nation's largest drugstore chain, and global health care leader Heritage Provider Network, along with its Arizona operating affiliate Arizona Priority Care, today announced a clinical care collaboration agreement.

18 Jun 2014

Researchers identify six gene loci associated with pulmonary diseases

In their investigations or so-called genome-wide association studies, the team of researchers compared the genetic profile of study participants to the forced vital capacity (FVC), a volume parameter of lung function.

18 Jun 2014

Research explores links between planet's health and human health

United Nations University will help pioneer a fresh trail in global health research, exploring links between the planet's health and human health at an institute in Kuala Lumpur generously supported by Malaysia.

17 Jun 2014

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

17 Jun 2014

Respiratory News and Research

Queen's doctor plays key role in major breakthrough to change lives of cystic fibrosis sufferers

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

St. Mary's Medical Center honored with Healthgrades 2014 Women's Health Excellence Award

Trevena's Phase 1b data for TRV130 published in the journal Pain

Nearly 4% of U.S. babies are born before full-term without medical indication, study finds

Forest Laboratories reports positive results from three Phase III trials of vilazodone for GAD treatment

Scientists turn to old class of antibiotics to fight superbugs resistant to modern medicine

Private insurers clamp down on drug prices

Aradigm begins Pulmaquin Phase III study for treatment of non-CF BE

Trevena reports positive results from TRV734 Phase 1 trial for treating acute/chronic pain

First Edition: June 23, 2014

National, state air pollution controls decrease death rates in North Carolina

New mobile app can measure respiratory rate in children 6 times faster than manual method

Research provides unique insight into lncRNAs that regulate lung development

Researchers identify MERS-related abnormality distribution on CT imaging of patients

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

Walgreens, Heritage Provider Network sign clinical care collaboration agreement

Researchers identify six gene loci associated with pulmonary diseases

Research explores links between planet's health and human health

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News